SCHEMBL980218

SCHEMBL980218

COc1cc[c]c(Br)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28296746 0.78 FYN (0.31)
SCHEMBL28542391 0.77 ALDH1A1 (0.39)
SCHEMBL1637027 0.77 NQO1 (0.44)
SCHEMBL27688593 0.77 FBP1 (0.35)
SCHEMBL15066961 0.76 ALDH1A1 (0.41)
SCHEMBL6978764 0.75 CHRM2 (0.47)
SCHEMBL160135 0.74
SCHEMBL77754 0.74 CA1 (0.39)
SCHEMBL1067722 0.74 ALOX15 (0.39)
SCHEMBL28084471 0.74 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 201 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11351178-B2 Selective HDAC6 inhibitors ITALFARMACO SPA (IT) 2022-06-07 US claimed
US-20210128577-A1 Selective HDAC6 Inhibitors ITALFARMACO S.P.A. (IT) 2021-05-06 US claimed
CN-110642918-B Diosgenin derivative and preparation method and application thereof 山东师范大学 2021-01-08 CN claimed
CN-110642918-A Diosgenin derivative and preparation method and application thereof 山东师范大学 2020-01-03 CN claimed
CN-110546140-A selective HDAC6 inhibitors ITALFARMACO SPA 2019-12-06 CN claimed
EP-3562810-A1 SELECTIVE HDAC6 INHIBITORS Italfarmaco SpA (IT) 2019-11-06 EP claimed
WO-2018189340-A1 SELECTIVE HDAC6 INHIBITORS ITALFARMACO S.P.A. (IT) 2018-10-18 WO claimed
EP-2257167-B1 2-AMINOIMIDAZOLE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2015-07-22 EP claimed
WO-2014002109-A1 SUBSTITUTED TETRAZOLE COMPOUNDS AND PROCESS THEREOF RALLIS INDIA LIMITED (IN) 2014-01-03 WO claimed
US-8492387-B2 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease Merck, Sharp & Dohme, Corp. (US) 2013-07-23 US claimed
WO-2012164572-A1 SUBSTITUTED 4-ARYLTHIAZOLES AND PROCESS OF PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2012-12-06 WO claimed
US-20110034483-A1 2-AMINOIMIDAZOLE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Via EFS 2011-02-10 US claimed
EP-2257167-A1 2-AMINOIMIDAZOLE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE Merck Sharp & Dohme Corp. (US) 2010-12-08 EP claimed
WO-2009108550-A1 2-AMINOIMIDAZOLE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK & CO., INC. (US) 2009-09-03 WO claimed
CN-118255627-A Growth nutrient solution for cultivating passion fruit in barren soil 漳州城市职业学院 2024-06-28 CN disclosed
CN-118265453-A Protein aggregation inhibiting compounds for plant disease control 马克斯·普朗克科学促进学会 2024-06-28 CN disclosed
US-11970486-B2 Compounds and uses thereof JANSSEN PHARMACEUTICA NV (BE) 2024-04-30 US disclosed
EP-0320733-A2 2-tert.-butyl-5-isoxazolyl methylthio-3(2H)-pyridazin-3-one derivatives BASF Aktiengesellschaft (DE) 1989-06-21 EP disclosed
US-4824834-A TREATING GOUT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1989-04-25 US disclosed
EP-0269859-A2 Pyrazolotriazine compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-06-08 EP disclosed